Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1595888 NEW YORK, NY
Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$44,114,896
-$6,410,316 QoQ
Shares Held
1,464,638
-9.5% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Mar 31, 2026
CallValue
$34,891,008
CallShares
1,158,400
PutValue
$22,252,656
PutShares
738,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $182,242,360 across 41 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (24.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
This page 		1,464,638 $44,114,896
2 LQDA
Liquidia Corp
 795,884 $30,036,661
3 VTRS
Viatris Inc
 2,192,665 $29,622,903
4 HLN
Haleon plc
 2,291,768 $22,940,596
5 BCRX
Biocryst Pharmaceuticals Inc
 622,607 $5,927,217
6 HIMS
Hims & Hers Health, Inc.
 240,170 $4,985,929
7 AQST
Aquestive Therapeutics, Inc.
 1,030,050 $4,274,707
8 XERS
Xeris Biopharma Holdings, Inc.
 725,616 $4,208,572

All Filings in TEVA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $44,114,896 1,464,638
2026-03-31 $22,252,656 738,800
2026-03-31 $34,891,008 1,158,400
2025-12-31 $50,525,212 1,618,879
2025-12-31 $184,607,150 5,915,000
2025-12-31 $43,244,576 1,385,600
2025-09-30 $108,528,540 5,372,700
2025-09-30 $54,828,860 2,714,300
2025-09-30 $60,673,386 3,003,633
2025-06-30 $60,056,108 3,583,300
2025-06-30 $93,068,280 5,553,000
2025-06-30 $47,602,538 2,840,247
2025-03-31 $27,432,376 1,784,800
2025-03-31 $57,422,320 3,736,000
2025-03-31 $30,837,152 2,006,321
2024-12-31 $7,327,174 332,449
2024-12-31 $57,246,696 2,597,400
2024-12-31 $31,744,212 1,440,300
2024-09-30 $20,366,204 1,130,200
2024-09-30 $2,053,954 113,982
2024-09-30 $30,271,798 1,679,900
2024-06-30 $19,632,761 1,208,170
2024-03-31 $10,466,783 741,799
2023-12-31 $8,416,205 806,150
2023-09-30 $23,036,292 2,258,460
2023-06-30 $46,738,619 6,206,988
2023-03-31 $27,158,428 3,068,749
2022-12-31 $22,033,746 2,415,981
2022-09-30 $25,144,650 3,115,818
2022-06-30 $43,130,824 5,735,482
2022-03-31 $47,652,531 5,074,817
2022-03-31 $15,905,721 1,693,900
2022-03-31 $16,702,932 1,778,800
2021-12-31 $46,906,102 5,855,943
2021-12-31 $15,774,093 1,969,300
2021-12-31 $9,455,004 1,180,400
2021-09-30 $43,170,961 4,432,337
2021-09-30 $22,377,650 2,297,500
2021-09-30 $28,472,942 2,923,300
2021-06-30 $21,791,880 2,201,200
2021-06-30 $18,067,252 1,824,975
2021-06-30 $17,773,470 1,795,300
2021-03-31 $12,622,452 1,093,800
2021-03-31 $25,250,073 2,188,048
2021-03-31 $15,677,090 1,358,500
2020-12-31 $16,831,751 1,744,223
2020-12-31 $15,822,140 1,639,600
2020-12-31 $8,326,020 862,800
2020-09-30 $9,241,557 1,025,700
2020-09-30 $6,316,010 701,000

Report a Problem

Category
Description
Email (optional, for follow-up)